CUFinder

Max von Suskil

Max von Suskil

Rowan University

H-index: 3

North America-United States

Contact Max von Suskil

About Max von Suskil

Max von Suskil, With an exceptional h-index of 3 and a recent h-index of 3 (since 2020), a distinguished researcher at Rowan University, specializes in the field of Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Drug Resistance Can be Overcome in Multiple Myeloma and Acute Myeloid Leukemia By Targeting Mcl-1 with the Small Chemical KS18

Cancer on fire: role of inflammation in prevention and treatment

Mcl-1 inhibition: managing malignancy in multiple myeloma

Bruton’s tyrosine kinase targeting in multiple myeloma

Bruton’s Tyrosine Kinase Signaling and Advancement in Multiple Myeloma Therapy

Max von Suskil Information

University

Position

M.S. in Pharmaceutical Sciences

Citations(all)

35

Citations(since 2020)

35

Cited By

0

hIndex(all)

3

hIndex(since 2020)

3

i10Index(all)

2

i10Index(since 2020)

2

Email

University Profile Page

Google Scholar

Max von Suskil Skills & Research Interests

Oncology

Top articles of Max von Suskil

Drug Resistance Can be Overcome in Multiple Myeloma and Acute Myeloid Leukemia By Targeting Mcl-1 with the Small Chemical KS18

Blood

2023/11/28

Robert Chitren
Robert Chitren

H-Index: 3

Max Von Suskil
Max Von Suskil

H-Index: 0

Subash Jonnalagadda
Subash Jonnalagadda

H-Index: 13

Cancer on fire: role of inflammation in prevention and treatment

2022/1/1

Max Von Suskil
Max Von Suskil

H-Index: 0

Robert Chitren
Robert Chitren

H-Index: 3

Mcl-1 inhibition: managing malignancy in multiple myeloma

2021/7/19

Max Von Suskil
Max Von Suskil

H-Index: 0

Manoj Pandey
Manoj Pandey

H-Index: 7

Bruton’s tyrosine kinase targeting in multiple myeloma

2021/5/27

Max Von Suskil
Max Von Suskil

H-Index: 0

Robert Chitren
Robert Chitren

H-Index: 3

Kishore B Challagundla
Kishore B Challagundla

H-Index: 16

Bruton’s Tyrosine Kinase Signaling and Advancement in Multiple Myeloma Therapy

Advances in Cancer Signal Transduction and Therapy

2020/10/5

Max Von Suskil
Max Von Suskil

H-Index: 0

See List of Professors in Max von Suskil University(Rowan University)